![Michael Matin](https://www.hdltherapeutics.com/wp-content/uploads/2021/10/Matin4a.png)
Michael A. Matin
Chairman & CEO
H. Bryan Brewer, MD
Chief Scientific Officer
![](https://www.hdltherapeutics.com/wp-content/uploads/2021/04/headshot-brewer-01.png)
![](http://new.hdltherapeutics.com/wp-content/uploads/2021/04/headshot-perlman-01.png)
Timothy J. Perlman
Chief Technology Officer
Michael McCann
Chief Commercial Officer
![](http://new.hdltherapeutics.com/wp-content/uploads/2021/04/headshot-mccann-01.png)
![](https://www.hdltherapeutics.com/wp-content/uploads/2021/04/headshot-carr-01.png)
Lori A. Carr, RAC, CQA, RABQSA
VP, Quality Management & Regulatory Affairs
Chairman & CEO
Chief Scientific Officer
Chief Technology Officer
Chief Commercial Officer
VP, Quality Management & Regulatory Affairs